{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:01:14Z","timestamp":1768636874855,"version":"3.49.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","award":["1.8.029.20N"],"award-info":[{"award-number":["1.8.029.20N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To investigate the reliability of durometry in systemic sclerosis (SSc), by means of a systematic review and additional pilot study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Literature was systematically reviewed according to the PRISMA guidelines to identify all original studies assessing the reliability of durometry in SSc. Additionally, in the pilot study, intra-rater reliability was evaluated in a first cohort of 74 SSc patients (61 female, 13 LSSc\/53 LcSSc\/8 DcSSc). In a second separate set of 30 SSc patients (21 female, 4 LSSc\/20 LcSSc\/6 DcSSc), intra- and inter-rater reliability were evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Only two unique records identified through the systematic review were qualified to generate conclusions. Regarding intra-rater reliability, Kissin reported excellent intra-class correlation coefficient values (ICC, 0.86\u20130.94) for measurements at nine skin sites in two DcSSc patients. Merkel and Kissin described, both in five DcSSc patients, good to excellent inter-rater reliability (ICC, 0.82\u20130.96 and 0.61\u20130.85) for measurements at respectively, six and nine skin sites. In our pilot study, ICC for intra-rater reliability at 17 standardized skin sites were excellent in both cohorts, ranging 0.93\u20130.99 and 0.78\u20130.98, respectively. ICC for inter-rater reliability at 17 standardized skin sites were good to excellent 0.63\u20130.93, except for the feet (0.48 and 0.52).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The preliminary findings in the literature are supported by our pilot study in which we have attested the reliability of durometry in SSc patients. However, prior to including durometry as an (additional) outcome measure in SSc clinical trials, its validation status in the assessment of skin fibrosis needs to be completely attested.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab028","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T20:12:59Z","timestamp":1610827979000},"page":"2099-2108","source":"Crossref","is-referenced-by-count":6,"title":["Durometry in SSc: The hard facts. A systematic literature review and additional pilot study"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-7060","authenticated-orcid":false,"given":"Amber","family":"Vanhaecke","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Ghent University"},{"name":"Department of Rheumatology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Verschuere","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ghent University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Vilela","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Heeman","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ghent University"},{"name":"Department of Rheumatology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Cutolo","sequence":"additional","affiliation":[{"name":"Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genoa, IRCCS San Martino Polyclinic Hospital, Genoa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6271-7945","authenticated-orcid":false,"given":"Vanessa","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Ghent University"},{"name":"Department of Rheumatology, Ghent University Hospital, Ghent, Belgium"},{"name":"Unit for Molecular Immunology and Inflammation, VIB Center for Inflammation Research (IRC), Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"issue":"10","key":"2021051419085770300_keab028-B1","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1995.01690220066013","article-title":"Reproducible measurements to quantify cutaneous involvement in scleroderma","volume":"131","author":"Aghassi","year":"1995","journal-title":"Arch Dermatol"},{"key":"2021051419085770300_keab028-B2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/1744666X.2019.1614915","article-title":"Pathophysiology of systemic sclerosis: current understanding and new insights","volume":"15","author":"Cutolo","year":"2019","journal-title":"Expert Rev Clin Immunol"},{"key":"2021051419085770300_keab028-B3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00281-015-0517-1","article-title":"The immunopathology of systemic sclerosis. Introduction","volume":"37","author":"van Laar","year":"2015","journal-title":". Semin Immunopathol"},{"key":"2021051419085770300_keab028-B4","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/art.1780330828","article-title":"Skin score. A semiquantitative measure of cutaneous involvement that improves prediction of prognosis in systemic sclerosis","volume":"33","author":"Clements","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B5","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B6","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.22721","article-title":"Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model","volume":"56","author":"Shand","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B7","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B8","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"2021051419085770300_keab028-B9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s10067-004-0970-z","article-title":"Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms","volume":"24","author":"Danieli","year":"2005","journal-title":"Clin Rheumatol"},{"key":"2021051419085770300_keab028-B10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/art.1780220205","article-title":"Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma","volume":"22","author":"Rodnan","year":"1979","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","article-title":"Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Black","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B12","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0190-9622(99)70246-X","article-title":"Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)","volume":"41","author":"Enomoto","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"2021051419085770300_keab028-B13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/art.22289","article-title":"Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192","volume":"56","author":"Denton","year":"2007","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B14","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/ard.2008.096123","article-title":"An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis","volume":"68","author":"Denton","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021051419085770300_keab028-B15","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B16","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements","year":"1995","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/art.22093","article-title":"Durometry for the assessment of skin disease in systemic sclerosis","volume":"55","author":"Kissin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/art.23564","article-title":"Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial","volume":"59","author":"Merkel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/rheumatology\/36.2.244","article-title":"Plicometer skin test: a new technique for the evaluation of cutaneous involvement in systemic sclerosis","volume":"36","author":"Nives Parodi","year":"1997","journal-title":"Br J Rheumatol"},{"key":"2021051419085770300_keab028-B20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/rheumatology\/38.10.992","article-title":"Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy","volume":"38","author":"Filaci","year":"1999","journal-title":"Rheumatology (Oxford"},{"key":"2021051419085770300_keab028-B21","first-page":"233","article-title":"Long-term treatment of patients affected by systemic sclerosis with cyclosporin A","volume":"16","author":"Basso","year":"2001","journal-title":"Ann Ital Med Int"},{"key":"2021051419085770300_keab028-B22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1346-8138.1996.tb03992.x","article-title":"Measurement of skin elastic properties with a new suction device (II): systemic sclerosis","volume":"23","author":"Ishikawa","year":"1996","journal-title":"J Dermatol"},{"key":"2021051419085770300_keab028-B23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0190-9622(96)90601-5","article-title":"Quantification of cutaneous sclerosis with a skin elasticity meter in patients with generalized scleroderma","volume":"35","author":"Enomoto","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"2021051419085770300_keab028-B24","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/rheumatology\/keg435","article-title":"Seventeen-point dermal ultrasound scoring system\u2013a reliable measure of skin thickness in patients with systemic sclerosis","volume":"42","author":"Moore","year":"2003","journal-title":"Rheumatology (Oxford"},{"key":"2021051419085770300_keab028-B25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1529-8019.2007.00116.x","article-title":"Ultrasound as an outcome measure to assess disease activity in disorders of skin thickening: an example of the use of radiologic techniques to assess skin disease","volume":"20","author":"Bendeck","year":"2007","journal-title":"Dermatol Ther"},{"key":"2021051419085770300_keab028-B26","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/ard.2009.114843","article-title":"High frequency ultrasound measurement of digital dermal thickness in systemic sclerosis","volume":"69","author":"Kaloudi","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021051419085770300_keab028-B27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/rheumatology\/kem307","article-title":"High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease","volume":"47","author":"Hesselstrand","year":"2008","journal-title":"Rheumatology (Oxford"},{"key":"2021051419085770300_keab028-B28","doi-asserted-by":"crossref","first-page":"v53","DOI":"10.1093\/rheumatology\/kex202","article-title":"Assessment of skin involvement in systemic sclerosis","volume":"56","author":"Kumanovics","year":"2017","journal-title":"Rheumatology (Oxford"},{"key":"2021051419085770300_keab028-B29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13075-017-1270-8","article-title":"Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis","volume":"19","author":"Sulli","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2021051419085770300_keab028-B30","first-page":"1630","article-title":"Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6","volume":"30","author":"Merkel","year":"2003","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B31","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00002281-199711000-00014","article-title":"Skin involvement as a relevant outcome measure in clinical trials of systemic sclerosis","volume":"9","author":"Seibold","year":"1997","journal-title":"Curr Opin Rheumatol"},{"key":"2021051419085770300_keab028-B32","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11926-007-0010-5","article-title":"Outcome measures in systemic sclerosis: an update on instruments and current research","volume":"9","author":"Khanna","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"2021051419085770300_keab028-B34","first-page":"84","article-title":"The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis","volume":"25","author":"Furst","year":"1998","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B35","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/ard.2006.066530","article-title":"The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis","volume":"66","author":"Czirjak","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021051419085770300_keab028-B36","first-page":"1194","article-title":"Systemic sclerosis \u2013 continuing progress in developing clinical measures of response","volume":"34","author":"Furst","year":"2007","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"2021051419085770300_keab028-B38","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0190-9622(93)70150-R","article-title":"Use of a durometer to assess skin hardness","volume":"29","author":"Falanga","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"2021051419085770300_keab028-B39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/bjd.14103","article-title":"Durometry as an outcome measure in juvenile localized scleroderma","volume":"174","author":"Poff","year":"2016","journal-title":"Br J Dermatol"},{"key":"2021051419085770300_keab028-B40","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3899\/jrheum.181097","article-title":"Core domain set selection according to OMERACT filter 2.1: the OMERACT methodology","volume":"46","author":"Maxwell","year":"2019","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B41","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00296-011-1993-9","article-title":"The correlation between durometer score and modified Rodnan skin score in systemic sclerosis","volume":"32","author":"Moon","year":"2012","journal-title":"Rheumatol Int"},{"key":"2021051419085770300_keab028-B42","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1002\/art.22186","article-title":"Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis","volume":"54","author":"Kissin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B43","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/acr.22339","article-title":"Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis","volume":"66","author":"Wiese","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2021051419085770300_keab028-B44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Int Med"},{"key":"2021051419085770300_keab028-B45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B46","first-page":"1573","article-title":"Jr. Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"2021051419085770300_keab028-B47","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2021051419085770300_keab028-B48","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021051419085770300_keab028-B49","first-page":"127","article-title":"Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior","volume":"86","author":"Cicchetti","year":"1981","journal-title":"Am J Ment Defic"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab028\/36123167\/keab028.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2099\/37936071\/keab028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/5\/2099\/37936071\/keab028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T19:10:00Z","timestamp":1621019400000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/5\/2099\/6119397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,2,4]]},"published-print":{"date-parts":[[2021,5,14]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab028","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2021,2,4]]}}}